Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

The Increasing Number of Therapeutic Drugs, Need for Immediate Relief Drive the Growth of Parenteral and Transdermal Excipients

RELEASE DATE
16-Jul-2014
REGION
North America
Research Code: NE52-01-00-00-00
SKU: CM00110-NA-MR_00427

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
CM00110-NA-MR_00427

$2,450.00

$1,837.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.

Table of Contents

Executive Summary

Research Scope and Methodology

Market Overview—Parenteral Excipients

Market Overview—Transdermal Excipients

Market Overview—Parenteral Excipient Types/Classification

Market Overview—Parenteral Excipient Functions

Market Overview—Transdermal Excipient Types/ Classification

Market Overview—Transdermal Excipients Functions

Advancement in Liquid Dosage Excipients—Value Chain

Parenteral Excipients Segment—Drivers and Restraints

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Transdermal Excipients Segment—Drivers and Restraints

Drivers Explained

Drivers Explained (continued)

Restraints Explained

Market Engineering Measurements

Total Transdermal and Parenteral Excipients Market—Revenue and Volume Forecast

Revenue and Volume Forecast Discussion

Parenteral Excipients Segment—Pricing by Product Type

Parenteral Excipients Segment—Pricing by Product Type (continued)

Transdermal Excipients Segment—Pricing by Product Type

Transdermal Excipients Segment—Pricing by Product Type (continued)

Transdermal and Parenteral Excipients Market—Pricing by Product Type Discussion

Excipients for Parenteral Products—Suppliers

Excipients for Parenteral Products—Suppliers (continued)

Excipients for Transdermal Products—Suppliers

Market Share Analysis—Ranking of Suppliers for Selected Excipients

Competitive Analysis—Excipients in Marketed Parenteral Products

Competitive Analysis—Excipients in Marketed Parenteral Products (continued)

Competitive Analysis—Excipients in Marketed Parenteral Products (continued)

Competitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview

Competitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview (continued)

Transdermal and Parenteral Excipients Market—Competitive Factors

Transdermal and Parenteral Excipients Market—Competitive Factors Discussion

Transdermal and Parenteral Excipients Market—Competitive Factors Discussions (continued)

Company Profile of Key Market Participants—BASF

Company Profile of Key Market Participants—BASF (continued)

Company Profile of Key Market Participants—Dow Chemicals

Company Profile of Key Market Participants—Dow Chemicals (continued)

Company Profile of Key Market Participants—Gattefosse

Company Profile of Key Market Participants—Gattefosse (continued)

Parenteral Excipients Segment Breakdown

Excipients for Parenteral Products

Excipients for Parenteral Products—Technology Overview

Excipients for Parenteral Products—Technology Overview (continued)

Parenteral Excipients Segment—Market Engineering Measurement

Parenteral Excipients Segment—Revenue and Volume Forecast

Revenue and Volume Forecast Discussion

Parenteral Excipients Segment—Percent Volume by Excipient Type

Percent Volume by Excipient Type Discussion

Percent Volume by Excipient Type Discussion (continued)

Transdermal Excipients Segment Breakdown

Excipients for Transdermal Products—Technology Overview

Excipients for Transdermal Products—Technology Overview (continued)

Excipients for Transdermal Products—Technology Overview (continued)

Market Engineering Measurements—Transdermal Excipients Segment

Transdermal Excipients Segment—Revenue and Volume Forecast

Revenue and Volume Forecast Discussion

Transdermal Excipients Segment—Percent Volume by Excipient Type

Percent Volume by Excipient Type Discussion

Percent Volume by Excipient Type Discussion (continued)

Transdermal and Parenteral Excipients Market—Regional Breakdown

Transdermal and Parenteral Excipients Market—Regional Breakdown Discussion

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.
More Information
No Index Yes
Podcast No
Author Nandhini Rajagopal
Industries Chemicals and Materials
WIP Number NE52-01-00-00-00
Is Prebook No